STERIS Announces Financial Results for Fiscal 2027 First Quarter

manilatimes.net · 2026-08-05

Fiscal 2027 first quarter revenue increased 7%; constant currency organic revenue growth was 6% Fiscal 2027 first quarter as reported diluted EPS increased to $2.04; adjusted EPS per diluted share increased to $2.59Targeted restructuring plan announced associated with new Formulated Chemistries Center of Excellence in North Carolina DUBLIN, IRELAND, Aug. 05, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) ('STERIS” or the 'Company”) today announced financial results for its fiscal 2027 first quarter ended June 30, 2026. Total revenue for the first quarter of fiscal 2027 increased 7% to $1.5 billion compared with $1.4 billion in the first quarter of fiscal 2026. Constant currency organic revenue growth was 6% in the first quarter.

TickrTrends take: STERIS reported financial results for its fiscal 2027 first quarter, providing updated operational and financial performance data for investors monitoring the company's fundamentals. Given TickrTrends' current assessment that STE is undervalued, valuation-focused readers should examine whether the quarter's results support stronger pricing relative to healthcare sector peers or validate the disconnect between the stock's current market value and its underlying business performance. Key metrics from this earnings report will be instrumental in determining whether the undervalued designation reflects genuine opportunity or changing business conditions that merit reassessment.

Read the full story at manilatimes.net →